• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

康复期无症状或轻症至中度严重急性呼吸综合征冠状病毒 2 感染的医护人员体液和 T 细胞免疫进行性和并行下降。

Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

机构信息

Department of Infectious Diseases, Ramon y Cajal Hospital, Madrid, Spain.

Laboratory of Immunovirology, Ramón y Cajal Hospital, Madrid, Spain.

出版信息

J Infect Dis. 2021 Jul 15;224(2):241-245. doi: 10.1093/infdis/jiab242.

DOI:10.1093/infdis/jiab242
PMID:33961690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8136002/
Abstract

We investigated the duration of humoral and T-cell immune response in paired samples among 22 convalescent healthcare workers (HCWs). A median of 1.8 months after diagnosis, T-cell response was significantly lower in HCWs with early loss of antibodies (6 cases [27%]). After 5.1 months, antibody decline was observed in 77% of cases (41% seroreverted; P < .01), and 36% had lost T-cell response (75% lost response to spike protein). Persistence of immune response was observed in those who developed a greater adaptive immune response. Our data point to the initial immune response as the relevant player in coronavirus disease 2019 duration of protection.

摘要

我们调查了 22 名恢复期医护人员(HCWs)配对样本中的体液和 T 细胞免疫反应持续时间。在诊断后中位数为 1.8 个月时,抗体早期丢失的 HCWs 中的 T 细胞反应明显降低(6 例[27%])。5.1 个月后,77%的病例出现抗体下降(41%血清学转换;P<.01),36%的病例失去 T 细胞反应(75%对刺突蛋白失去反应)。在那些产生更大适应性免疫反应的人中观察到免疫反应的持久性。我们的数据表明,初始免疫反应是导致 2019 年冠状病毒病保护持续时间的相关因素。

相似文献

1
Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.康复期无症状或轻症至中度严重急性呼吸综合征冠状病毒 2 感染的医护人员体液和 T 细胞免疫进行性和并行下降。
J Infect Dis. 2021 Jul 15;224(2):241-245. doi: 10.1093/infdis/jiab242.
2
The fragility of humoral immunity as a physiological safety marker for healthcare workers to return after COVID-19 convalescence.体液免疫作为医护人员新冠康复后返岗的生理安全标志物的脆弱性。
J Microbiol Immunol Infect. 2021 Feb;54(1):141-143. doi: 10.1016/j.jmii.2020.08.012. Epub 2020 Aug 19.
3
IFN-γ cell response and IFN-γ release concordance after in vitro SARS-CoV-2 stimulation.体外 SARS-CoV-2 刺激后 IFN-γ 细胞反应和 IFN-γ 释放的一致性。
Eur J Clin Invest. 2021 Dec;51(12):e13636. doi: 10.1111/eci.13636. Epub 2021 Jun 24.
4
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.在 COVID-19 患者中,功能性 SARS-CoV-2 特异性 T 细胞的早期诱导与快速病毒清除和轻症疾病相关。
Cell Rep. 2021 Feb 9;34(6):108728. doi: 10.1016/j.celrep.2021.108728. Epub 2021 Jan 21.
5
Mild Cytokine Elevation, Moderate CD4 T Cell Response and Abundant Antibody Production in Children with COVID-19.儿童 COVID-19 患者表现为轻度细胞因子升高、中度 CD4+T 细胞应答和丰富的抗体产生。
Virol Sin. 2020 Dec;35(6):734-743. doi: 10.1007/s12250-020-00265-8. Epub 2020 Jul 22.
6
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study.SARS-CoV-2 感染具有预先存在的 T 细胞反应的医护人员:一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Jun;27(6):916.e1-916.e4. doi: 10.1016/j.cmi.2021.02.020. Epub 2021 Mar 2.
7
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.COVID-19 恢复期多发性硬化症患者对 SARS-CoV-2 的体液和细胞反应。
Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). doi: 10.1212/NXI.0000000000001143. Print 2022 Mar.
8
Measurement of SARS-CoV-2-Specific Humoral and Cellular Immunity in Coronavirus Disease 2019 Convalescent Health Care Workers in Iraq.评估伊拉克 2019 冠状病毒病康复期医护人员的 SARS-CoV-2 特异性体液和细胞免疫。
Arch Razi Inst. 2021 Nov 30;76(5):1255-2127. doi: 10.22092/ari.2021.356135.1785. eCollection 2021 Nov.
9
Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.在比利时一家教学医院中,COVID-19 医护人员的临床特征和体液免疫应答。
J Hosp Infect. 2020 Dec;106(4):713-720. doi: 10.1016/j.jhin.2020.09.018. Epub 2020 Sep 18.
10
Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.波兰一家儿科三级医院医护人员中针对 SARS-CoV-2 的 IgG 抗体流行率。
PLoS One. 2021 Apr 1;16(4):e0249550. doi: 10.1371/journal.pone.0249550. eCollection 2021.

引用本文的文献

1
Sequential immunotherapy: towards cures for autoimmunity.序贯免疫疗法:走向自身免疫病的治愈之路。
Nat Rev Drug Discov. 2024 Jul;23(7):501-524. doi: 10.1038/s41573-024-00959-8. Epub 2024 Jun 5.
2
mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection.mRNA 基于的 SARS-CoV-2 Comirnaty 疫苗在既往无感染个体中引发微弱和短暂的特异性记忆 B 细胞反应。
Front Immunol. 2023 Jun 29;14:1127379. doi: 10.3389/fimmu.2023.1127379. eCollection 2023.
3
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.既往常见人冠状病毒暴露对 mRNA 疫苗接种后 SARS-CoV-2 特异性 T 细胞和记忆 B 细胞应答的影响。
Viruses. 2023 Feb 24;15(3):627. doi: 10.3390/v15030627.
4
Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)特异性记忆B细胞对血清学阴性医护人员接种基于mRNA的Comirnaty疫苗后免疫反应的影响。
Front Microbiol. 2022 Sep 23;13:1002748. doi: 10.3389/fmicb.2022.1002748. eCollection 2022.
5
Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination.一项前瞻性起始队列研究中SARS-CoV-2再次感染的风险:COVID-19疫苗接种的影响
J Clin Med. 2022 Jun 10;11(12):3352. doi: 10.3390/jcm11123352.
6
The effect of age on the magnitude and longevity of Th1-directed CD4 T-cell responses to SARS-CoV-2.年龄对 SARS-CoV-2 诱导的 Th1 定向 CD4 T 细胞反应的幅度和持久性的影响。
Immunology. 2022 Jul;166(3):327-340. doi: 10.1111/imm.13475. Epub 2022 Apr 22.
7
Dominant CD8 T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination.新冠病毒感染中占主导地位的靶向核衣壳的CD8 T细胞及疫苗接种引发的广泛靶向刺突蛋白反应
Front Immunol. 2022 Feb 22;13:835830. doi: 10.3389/fimmu.2022.835830. eCollection 2022.
8
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study.SARS-CoV-2 抗体和 T 细胞反应在 COVID-19 一年后,以及疫苗加强针的效果:一项前瞻性队列研究。
J Infect. 2022 Feb;84(2):171-178. doi: 10.1016/j.jinf.2021.12.003. Epub 2021 Dec 9.
9
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.BNT162b2 mRNA COVID-19 疫苗的反应原性:免疫的关键作用。
Vaccine. 2021 Dec 17;39(51):7367-7374. doi: 10.1016/j.vaccine.2021.10.074. Epub 2021 Nov 11.
10
Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.COVID-19 与疫苗接种后的免疫反应:医务人员随访研究超过 1 年。
Infection. 2022 Apr;50(2):439-446. doi: 10.1007/s15010-021-01703-9. Epub 2021 Sep 25.